Novo Nordisk invests 8.5 billion DKK in new Odense facility

Despite Novo’s announcement that its growth abroad will be larger than in Denmark, the company announced this morning an 8.5 billion DKK investment for a new facility in Odense. This is the first time the company has established a new production site in Denmark this century.

(photo: Novo Nordisk)

Novo Nordisk has revealed plans to invest 8.5 billion Danish kroner in a new production facility in Odense, Denmark. This is the first time the company has established a new production site in Denmark this century, and it means that even if the pharma giant expands further abroad in the coming years, its birthplace remains […]


Gain unlimited access to all of The Copenhagen Post

Our independent reporting can only be published with support from our readers.

Monthly subscription

119

DKK/month.

(Billed once a month)

Give us a try

6 month subscription

99

DKK/month.

(Billed twice a year)

Save 120 DKK

Yearly subscription

79

DKK/month.

(Billed once a year)

Save 480 DKK

Save with a company subscription?